Analyses of immune status of patients with gastrointestinal cancer

Analyses of immune status of patients with gastrointestinal cancer - Immune monitoring in GI cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000019129

Enrollment

300

Registered

2015-09-27

Start date

2015-09-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with histologically confirmed or clinically suspected advanced cancer or malignant tumor of following descriptions; 1.gastric cancer 2.Esophageal cancer 3.colorectal cancer 4. GIST 2) Planned to receive surgery or systemic chemotherapy (one or more enrollment is possible per patient) 3) Plan to acquire sufficient tumor materials or sufficient archival materials to analyze 4) Written informed consent was obtained

Exclusion criteria

Exclusion criteria: 1) Patient is judged by the investigator to be inappropriate for study participation for any reason.

Design outcomes

Primary

Measure	Time frame
immune profile in gastrointestinal cancers	—

Secondary

Measure	Time frame
Association between immune profile and clinicopatholigical features as well as treatment response and prognosis	—

Countries

Japan

Contacts

Public ContactKohei Shitara

National Cancer Center Hospital East Gastrointestinal Oncology Division

kshitara@east.ncc.go.jp04-7133-1111

Outcome results